-
1.发明申请公开(公告)号：US20200276402A1
公开(公告)日：2020-09-03
申请号：US16647475
申请日：2018-08-17
发明人： Shunji Haruta , Genji Satoyoshi , Hideaki Mishima
摘要： A nozzled cartridge (20) for storing medicine, according to an aspect of the present application, includes a medicine container (21) that is to be filled with a predetermined quantity of a powdered medicine, a nozzle portion (22) that is formed on the medicine container (21) and that ejects the powdered medicine, a closing member (24) that closes an opening (22a) in the nozzle portion (22), and a valve member (25) that functions as a plug to close another opening (23a) in the medicine container (21), and that is opened when administering medicine. The nozzled cartridge (20) is detachably mountable to a sprayer (30) when administering medicine.
-
公开(公告)号：US20200046037A1
公开(公告)日：2020-02-13
申请号：US16342975
申请日：2017-10-16
发明人： Ryoichi NAGATA
摘要： To provide a method for producing brassieres that can prevent sagging of breasts, achieve effortless bust uplift, and immobilize the breasts when prone. A brassiere production method comprising a step for determining the shape of a region that comprises a breast (15) of a subject (11) when a nipple (13) of the subject (11) is turned vertically downward. An example of the state in which a nipple (13) is turned vertically downward is a state in which the subject is immobilized on a loading table (21) and, compared to the subject's nipple (13), the subject's back is in the direction of the loading table.
-
公开(公告)号：US10195139B2
公开(公告)日：2019-02-05
申请号：US13649515
申请日：2012-10-11
发明人： Ryoichi Nagata , Shunji Haruta
IPC分类号： A61K9/00 , A61K31/4535 , A61K9/16 , A61K38/00 , A61K45/06 , A61K31/4045 , A61K31/4178 , A61K31/4375 , A61K31/485 , A61K31/573 , A61K9/48
摘要： Disclosed is a preparation for transnasal application, which has improved fluidability. Specifically disclosed is a preparation for transnasal application, which comprises at least a complex comprising a fluidability-improving component comprising a first crystalline cellulose (A) having specified powder properties, tricalcium phosphate (B) having specified powder properties, and a second crystalline cellulose (C) having specified powder properties or a starch (D) having specified powder properties, and physiologically active substance.
-
4.发明申请OCT3 ACTIVITY INHIBITOR CONTAINING IMIDAZOPYRIDINE DERIVATIVE AS ACTIVE COMPONENT, AND OCT3 DETECTION AGENT 审中-公开含有咪唑吡啶衍生物作为活性成分的OCT3活性抑制剂和OCT3检测剂公开(公告)号：US20150329540A1
公开(公告)日：2015-11-19
申请号：US14655729
申请日：2013-12-17
IPC分类号： C07D471/04
CPC分类号： A61K31/437 , A61K31/444 , A61K31/4453 , A61K31/496 , C07D471/04
摘要： [Problem] To provide an OCT3 activity inhibitor having a different basic skeleton than that of conventional OCT3 activity inhibitors.[Solution] This inhibitor of organic cation transporter 3 (OCT3) contains, as an active component, an imidazo[1,2-a]pyridine derivative, a pharmaceutically acceptable salt thereof, or a pharmaceutically acceptable solvate thereof
摘要翻译： [问题]提供具有与常规OCT3活性抑制剂不同的基本骨架的OCT3活性抑制剂。 [溶液]有机阳离子转运体3（OCT3）的抑制剂含有作为活性成分的咪唑并[1,2-a]吡啶衍生物，其药学上可接受的盐或其药学上可接受的溶剂合物
-
公开(公告)号：US20130273120A1
公开(公告)日：2013-10-17
申请号：US13828337
申请日：2013-03-14
发明人： Ryoichi NAGATA , Shunji HARUTA
IPC分类号： A61K39/145 , A61K39/05 , A61K39/00 , A61K39/08
CPC分类号： A61K39/0005 , A61K9/0043 , A61K9/19 , A61K39/05 , A61K39/08 , A61K39/12 , A61K39/145 , A61K2039/5252 , A61K2039/543 , C12N2760/16134 , Y02A50/388
摘要： Provided herein are methods for generating dry vaccine powder formulations. Dry vaccine powder formulations can be used for intranasal delivery. Also provided are methods for stimulating local mucosal and systemic immunity by intranasal vaccine delivery.
摘要翻译： 本文提供了产生干疫苗粉末制剂的方法。 干疫苗粉末制剂可用于鼻内递送。 还提供了通过鼻内疫苗递送刺激局部粘膜和全身免疫的方法。
-
公开(公告)号：US20230046122A1
公开(公告)日：2023-02-16
申请号：US17794249
申请日：2021-01-25
发明人： Ryoichi NAGATA
IPC分类号： E03D13/00
摘要： [Problem] To provide a urine scattering prevention device which does not give off a foul smell even when used, and which is easy to replace. [Solution] A urine scattering prevention device 1 includes a urine receiving portion 5 disposed in a urinal 3, and a leg portion 7 which supports the urine receiving portion 5 vertically upward.
-
公开(公告)号：US11559640B2
公开(公告)日：2023-01-24
申请号：US16647475
申请日：2018-08-17
发明人： Shunji Haruta , Genji Satoyoshi , Hideaki Mishima
摘要： A nozzled cartridge (20) for storing medicine, according to an aspect of the present application, includes a medicine container (21) that is to be filled with a predetermined quantity of a powdered medicine, a nozzle portion (22) that is formed on the medicine container (21) and that ejects the powdered medicine, a closing member (24) that closes an opening (22a) in the nozzle portion (22), and a valve member (25) that functions as a plug to close another opening (23a) in the medicine container (21), and that is opened when administering medicine. The nozzled cartridge (20) is detachably mountable to a sprayer (30) when administering medicine.
-
公开(公告)号：US20220183971A1
公开(公告)日：2022-06-16
申请号：US17595381
申请日：2020-05-01
发明人： Shunji HARUTA , Yo SONODA
摘要： An object of the present invention is to provide a powder formulation for intranasal administration, which efficiently exhibits a medicinal effect, and the like. The object can be achieved by a powder formulation for intranasal administration comprising composite particles in which an active ingredient and a water-insoluble polysaccharide are cohered to each other.
-
公开(公告)号：US11311615B2
公开(公告)日：2022-04-26
申请号：US15760341
申请日：2016-09-16
发明人： Shunji Haruta
IPC分类号： A61K9/19 , A61K39/145 , A61K47/38 , A61K47/36 , A61K9/16 , A61K9/00 , A61K9/14 , A61K39/12 , A61K39/00
摘要： Provided herein are vaccine compositions for example in a dry powder form for intranasal delivery, and their preparation methods. Also provided are methods of using vaccine compositions, for example in stimulating mucosal or systemic immune responses by delivering the vaccine compositions intranasally.
-
公开(公告)号：US20200093103A1
公开(公告)日：2020-03-26
申请号：US16475068
申请日：2017-12-27
发明人： Ryoichi Nagata , Yutaka Kawakami
IPC分类号： A01K61/10 , A23K20/174 , A23K20/184 , A23K50/80
摘要： Anguilliformes breeding water contains a thyroid hormone such as thyroxine, and a method for rearing anguilliformes includes a step for administering a thyroid hormone such as thyroxine, wherein the amount of the thyroid hormone to be administered changes as the anguilliforme fingerling changes from a transformation start phase (stage 1) to a transformation final phase (stage 2), and the amount of the thyroid hormone to be administered in the transformation final phase (stage 2) is less than the amount of the thyroid hormone to be administered in the transformation start phase (stage 1).
-
-
-
-
-
-
-
-
-
搜索结果
41 条记录 (耗时 0.031 秒)
